PTH2R is related to cell proliferation and migration in ovarian cancer: a multi-omics analysis of bioinformatics and experiments

Ovarian cancer is a common gynecological disease and seriously endangers women's health. Currently, there is still a lack of effective molecular markers for the diagnosis and treatment of ovarian cancer. The present study aimed to investigate the molecular markers associated with ovarian cancer...

Full description

Saved in:
Bibliographic Details
Published in:Cancer cell international 2022-04, Vol.22 (1), p.148-148, Article 148
Main Authors: Xiaowei, Wang, Tong, Lu, Yanjun, Qu, Lili, Fan
Format: Article
Language:English
Subjects:
Bioinformatics
Biomarkers
Cell migration
Cell proliferation
Cholecystokinin
Datasets
GEO
Gynecological diseases
Metastases
Multi-omics
Ovarian cancer
Primary Research
PTH2R
TCGA
Tumor cells
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ovarian cancer is a common gynecological disease and seriously endangers women's health. Currently, there is still a lack of effective molecular markers for the diagnosis and treatment of ovarian cancer. The present study aimed to investigate the molecular markers associated with ovarian cancer. The molecular and gene related to ovarian cancer were extracted from GEO database and TCGA database by bioinformatics, and the related genes and functions were further analyzed. The results were verified by qPCR, WB, CCK-8 and Transwell experiments. Data analysis showed that PTH2R gene was highly expressed in tumors, and 51 HUB genes were obtained. Finally, experimental verification showed that PTH2R gene was highly expressed in ovarian cancer, and PTH2R gene was involved in the proliferation, invasion and metastasis of ovarian cancer cells. After experimental verification, we found that knocking down the expression of PTH2R can inhibit the proliferation, invasion and migration of tumor cells.PTH2R is expected to become a new molecular marker for ovarian cancer.
ISSN:1475-2867
1475-2867
DOI:10.1186/s12935-022-02566-2